Involvement of Wiskott-Aldrich syndrome protein family verprolin-homologous protein (WAVE) and Rac1 in the phagocytosis of amyloid-β(1-42) in rat microglia

Journal of Pharmacological Sciences

Volumn 92, Issue 2, 2003, Pages 115-123

  Kitamura, Yoshihisa ^d   Shibagaki, Keiichi ^d   Takata, Kazuyuki ^d   Tsuchiya, Daiju ^d   Taniguchi, Takashi ^d   Gebicke Haerter, Peter J ^b   Miki, Hiroaki ^c   Takenawa, Tadaomi ^c   Shimohama, Shun ^a  

^a KYOTO UNIVERSITY   (Japan)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c UNIVERSITY OF TOKYO   (Japan)

^d KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid (1 42); Microglial phagocytosis; Rac1; Wiskott Aldrich syndrome protein family verprolin homologous protein (WAVE)

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; CYTOCHALASIN D; F ACTIN; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; PROTEIN CDC42; RAC1 PROTEIN; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN FAMILY VERPROLIN HOMOLOGOUS PROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN INTERACTING SH3 PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SHAPE; CELL SURFACE; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; IMMUNOREACTIVITY; LAMELLIPODIUM; MICROGLIA; NEWBORN; NONHUMAN; PHAGOCYTOSIS; PROTEIN FAMILY; PROTEIN LOCALIZATION; RAT;

EID: 0038645158     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.92.115     Document Type: Article

References (38)

1. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 1999;399 Suppl:A23-A31.
2. Kitamura Y, Taniguchi T, Shimohama S. Apoptotic cell death in neurons and glial cells: Implications for Alzheimer's disease. Jpn J Pharmacol. 1999;79:1-5.
3. Neuroinflammation working group: Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21:383-421.
4. In T'Veld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med. 2001;345:1515-1521.
5. Kettenmann H, Ransom BR, editors. Neuroglia. New York and Oxford: Oxford University Press; 1995.
6. Holcomb L, Gordon MN, McGowan E, et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med. 1998;4:97-100.
7. Takeuchi A, Irizarry MC, Duff K, et al. Age-related amyloid β deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid β precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol. 2000;157:331-339.
8. Jantzen PT, Connor KE, DiCarlo G, et al. Microglial activation and β-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J Neurosci. 2002;22:2246-2254.
9. Kreutzberg GW. Microglia: A sensor for pathological events in the CNS. Trends Neurosci. 1996;19:312-318.
10. Wegiel J, Wisniewski HM. The complex of microglial cells and amyloid star in three-dimensional reconstruction. Acta Neuropathol. 1990;81:116-124.
11. Stalder M, Phinney A, Probst A, Sommer B, Staufenbiel M, Jucker M. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am J Pathol. 1999;154:1673-1684.
12. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature. 1996;382:716-719.
13. Christie RH, Freeman M, Hyman BT. Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease. Am J Pathol. 1996;148:399-403.
14. Paresce DM, Ghosh RN, Maxfield FR. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron. 1996;17:553-565.
15. Schenk D. Amyloid-β immunotherapy for Alzheimer's disease: The end of the beginning. Nat Rev Neurosci. 2002;3:824-828.
16. Bard F, Cannon C, Barbour R, et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000;6:916-919.
17. DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM. Brain to plasma amyloid-β efflux: A measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science. 2002;295:2264-2267.
18. Wyss-Coray T, Lin C, Yan F, et al. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat Med. 2001;7:612-618.
19. Kakimura J, Kitamura Y, Taniguchi T, Shimohama S, Gebicke-Haerter PJ. BiP/GRP78-induced production of cytokines and uptake of amyloid-β(1 - 42) peptide in microglia. Biochem Biophys Res Commun. 2001;281:6-10.
20. Kakimura J, Kitamura Y, Takata K, et al. Microglial activation and amyloid-β clearance induced by exogenous heat-shock proteins [Summary]. FASEB J (February 25, 2002) 10.1096/fj.01-0530fje. FASEB J. 2002; 16:601-603.
21. Greenberg S. Signal transduction of phagocytosis. Trends Cell Biol. 1995;5:93-99.
22. Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci. 2000;113:3073-3084.
23. Hall A. Rho GTPases, the actin cytoskeleton. Science. 1998;279:509-514.
24. Miki H, Sasaki T, Takai Y, Takenawa T. Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP. Nature. 1998;391:93-96.
25. Miki H, Yamaguchi H, Suetsugu S, Takenawa T. IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling. Nature. 2000;408:732-735.
26. Takenawa T, Miki H. WASP and WAVE family proteins: Key molecules for rapid rearrangement of cortical actin filaments and cell movement. J Cell Sci. 2001;114:1801-1809.
27. Fukuoka M, Suetsugu S, Miki H, Fukami K, Endo T, Takenawa T. A novel Neural Wiskott-Aldrich syndrome protein (N-WASP) binding protein, WISH, induces Arp2/3 complex activation independent of Cdc42. J Cell Biol. 2001;152:471-482.
28. Fukuoka M, Miki H, Takenawa T. Identification of N-WASP homologs in human and rat brain. Gene. 1997;196:43-48.
29. Kitamura Y, Taniguchi T, Kimura H, Nomura Y, Gebicke-Haerter PJ. Interleukin-4-inhibited mRNA expression in mixed rat glial and in isolated microglial cultures. J Neuroimmunol. 2000;106:95-104.
30. Kaneko I, Tutumi S. Matters arising: Conformations of β-amyloid in solution. J Neurochem. 1997;68:438-439.
31. Kitamura Y, Ishida Y, Takata K, et al. Hyperbilirubinemia protects against focal ischemia in rats. J Neurosci Res. 2003;71:544-550.
32. Miura N, Asano A. Synergistic effect of colchicine and cytochalasin D on phagocytosis by peritoneal macrophages. Nature. 1976;261:319-321.
33. Miki H, Miura K, Takenawa T. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J. 1996;15:5326-5335.
34. Miki H, Suetsugu S, Takenawa T. WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac. EMBO J. 1998;17:6932-6941.
35. Allen WE, Jones GE, Pollard JW, Ridley AJ. Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. J Cell Sci. 1997;110:707-720.
36. Nobes CD, Hall A. Rho, Rac and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 1995;81:53-62.
37. Senior K. Dosing in phase II trial of Alzheimer's vaccine suspended. Lancet Neurol. 2002;1:3.
38. Kitamura Y, Nomura. Stress proteins and glial functions: Possible therapeutic targets for neurodegenerative disorders. Pharmacol Ther. 2003;97:35-53.